Digiceuticals Market Analysis

Use (Smart phone, Watches, Medical Device System)

In digiceuticals market, smartphones segment is poised to hold more than 38% share by 2036. The segment growth is on the account of the increasing number of smartphone users in the world. For instance, in 2021, the number of mobile users worldwide stood at 7.1 billion. Smartphone users are increasingly using their phones to get health information, track their data, and plan appointments.

Furthermore, smartphones are rapidly being outfitted with health sensors such as accelerometers, gyroscopes, heart rate monitors, and even pulse oximeters, allowing users to monitor vital indications like heart rate and blood pressure. The segment’s rapid expansion is on the account of these factors.

Application (Diabetes Management, Substance Abuse, Pulmonary Diseases, Alcohol and Smoking Addiction, Neurological Disorders)

In digiceuticals market, diabetes management segment is estimated to capture over 29% revenue share by 2036. The segment growth can be attributed to the increasing prevalence of diabetes, growing awareness about preventive measures, and rising government initiatives to provide better healthcare facilities for diabetic patients. According to IDF projections it is estimated that by 2045 around 783 million adults, which is one in eight individuals will live with diabetes. This represents a 46% increase. It is interesting to note that over 90% of diabetes patients are specifically diagnosed with type 2 diabetes.

Diabetes management requires regular monitoring of blood sugar levels and adjustment of medication accordingly. Digiceuticals allow people with diabetes to track their blood sugar levels remotely and alert them if they need to adjust their medication.

Our in-depth analysis of the digiceuticals market includes the following segments:

Use	Smart phone Watches Medical Device System
Application	Diabetes Management Substance Abuse Pulmonary Diseases Alcohol And Smoking Addiction Neurological Disorders
Distribution Channel	Hospitals Specialty clinics

Frequently Asked Questions (FAQ)

: The growth of the digiceuticals market is being driven by several factors, such as the rising popularity of digital health technologies, the increasing need for personalized healthcare, the increasing prevalence of chronic diseases, and the rising cost of traditional healthcare.

The market size of digiceuticals is anticipated to attain a CAGR of 33% over the forecast period, i.e., 2024-2036.

The major players in the market are Pear therapeutics Inc., Akili Interactive Labs, Inc., Chrono Therapeutics Inc., Click Therapeutics, Omada Health, Canary Health, Inc., Glooko, Inc., Propeller helath, Welldoc, Voluntis, and others.

The smartphone segment is anticipated to garner the largest market size of 38% by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share of 31% by the end of 2036 and provide more business opportunities in the future.

Digiceuticals Market Analysis